Skip to main content
. Author manuscript; available in PMC: 2022 Sep 6.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2020 Sep 6;110(1):227–236. doi: 10.1016/j.ijrobp.2020.08.014

Table 2.

Summary of series with patients with high-risk prostate cancer.

Cohort High-risk patients (N) Years post treatment FFBR rate (%)
Royal Marsden44 6 1.2 NR
Western Australia34 6 2.0 100.0
Georgetown54 8 2.0 87.5*
Virginia Hospital Center57 8 2.0 100.0
Vincenza53 17 3.0 94.4
Philadelphia62 18 5.0 86.7
Seoul61 29 5.0 90.9
RSSR39 33 2.0 89.8
Flushing48 38 5.0 68.6
Finland56 111 1.9 92.8
RPCR40 172 2.0 87.0
*

Crude estimate

Abbreviations: FFBR, freedom from biochemical relapse; NR, not reported; RSSR, Radiosurgery Society Registry; RPCR, Registry for Prostate Cancer Radiosurgery